Anti-nectin-4 antibody amanitin conjugates
US-2024181075-A1 · Jun 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
Emergence Therapeutics Ag patents
Emergence Therapeutics Ag holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 3 |
| First publication | Feb 1, 2024 |
| Latest publication | Jun 6, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2024 | 3 |
| Year | Patents |
|---|---|
| 2024 | 3 |
Recent patents
Latest publications where this party is an assignee.
Anti-nectin-4-antibody exatecan conjugates
US-2024173424-A1 · May 30, 2024 · US
Anti-nectin-4-antibodies and uses thereof
US-2024034791-A1 · Feb 1, 2024 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Anti-nectin-4 antibody amanitin conjugates
US-2024181075-A1 · Jun 6, 2024 · US
Anti-nectin-4-antibody exatecan conjugates
US-2024173424-A1 · May 30, 2024 · US
Anti-nectin-4-antibodies and uses thereof
US-2024034791-A1 · Feb 1, 2024 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C07K16/2803 | 3 |
| A61K47/6849 | 3 |
| A61K47/6803 | 3 |
| A61K47/6855 | 3 |
| A61P35/00 | 3 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |